Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome
Background and Objectives: A growing number of epidemiological studies have suggested that diabetes mellitus may increase cancer risk and is implicated in numerous other metabolic and inflammatory disorders. The increase in proinflammatory cytokines plays a major role in insulin resistance and leads...
Main Authors: | Mihai Cosmin Stan, Daniel Georgescu, Ciprian Camil Mireștean, Florinel Bădulescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/16/2647 |
Similar Items
-
Cetuximab-Taxanes-Platinum-Fluorouracil/Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation
by: Camil Ciprian MIRESTEAN, et al.
Published: (2023-03-01) -
Skin Cancers of the Head and Neck Region: the Real World Epidemiological and Therapeutic Data from the Cancer Registry of Dolj County
by: Camil Ciprian MIRESTEAN, et al.
Published: (2023-09-01) -
The Prognostic Value of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review
by: Camil Ciprian Mireștean, et al.
Published: (2023-11-01) -
Head and Neck Low Grade Chondrosarcoma—A Rare Entity
by: Camil Ciprian Mireștean, et al.
Published: (2023-09-01) -
Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review
by: Camil Ciprian Mireștean, et al.
Published: (2023-08-01)